InMode shares rise after prelim Q3 results beat estimates
** Israel-based medtech company InMode INMD.O shares climb
6.3% to $16
** Expects to deliver Q3 rev between $130 mln and $130.1
mln, beating expectations of $115.8 mln, as per LSEG data
** Co says proactively assessing relocation of certain
production activities outside of Israel
** 2 of 6 brokerages rate the stock "buy" or higher, 4
"hold"; their median PT is $20.40
** As of last close, stock down ~28.28% YTD
(Reporting by Ankita Bora in Bengaluru)
((Ankita.Bora@thomsonreuters.com))
Recent news on InMode
See all newsBrief: Inmode Haifa District Court Denied Sp Strategic Holdings' Request For Temporary Injunctive Relief In Its Entirety
InMode Ltd. reports results for the quarter ended June 30 - Earnings Summary
Brief: Inmode Q2 Revenue USD 95.589 Million Versus. Ibes Estimate USD 93 Million
InMode Q2 revenue beats estimates on steady U.S. demand
Brief: Steel Partners Urges Inmode Shareholders To Vote Against The Re-Election Of Dr. Hadar Ron And Against Extraordinary Special Committee Compensation At The July 30 Annual General Meeting